Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
Phase II Evaluation of Oxaliplatin in the Treatment of Recurrent or Persistent Endometrial Carcinoma
RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, work in different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have persistent or recurrent endometrial cancer.
調査の概要
詳細な説明
OBJECTIVES:
- Determine the antitumor activity of oxaliplatin in terms of response rate in patients with persistent or recurrent endometrial carcinoma that is refractory to curative or established therapy.
- Determine the nature and degree of toxicity of this treatment regimen in these patients.
OUTLINE: This is a multicenter study.
Patients receive oxaliplatin IV over 2 hours on day 1. Treatment repeats every 3 weeks in the absence of disease progression or unacceptable toxicity.
Patients are followed every 3 months for 2 years and then every 6 months for 3 years.
PROJECTED ACCRUAL: Approximately 19-51 patients will be accrued for this study.
研究の種類
段階
- フェーズ2
連絡先と場所
研究場所
-
-
Alabama
-
Birmingham、Alabama、アメリカ、35294-3300
- University of Alabama at Birmingham Comprehensive Cancer Center
-
-
Arizona
-
Phoenix、Arizona、アメリカ、85006-2726
- CCOP - Western Regional, Arizona
-
-
California
-
Orange、California、アメリカ、92868
- Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
-
-
Colorado
-
Denver、Colorado、アメリカ、80010
- University of Colorado Cancer Center at University of Colorado Health Sciences Center
-
-
Connecticut
-
New Britain、Connecticut、アメリカ、06052
- New Britain General Hospital
-
-
Delaware
-
Newark、Delaware、アメリカ、19713
- CCOP - Christiana Care Health Services
-
-
Illinois
-
Chicago、Illinois、アメリカ、60637-1470
- University of Chicago Cancer Research Center
-
Chicago、Illinois、アメリカ、60612
- MBCCOP - University of Illinois at Chicago
-
Decatur、Illinois、アメリカ、62794-9640
- CCOP - Central Illinois
-
Evanston、Illinois、アメリカ、60201
- CCOP - Evanston
-
Urbana、Illinois、アメリカ、61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
South Bend、Indiana、アメリカ、46617
- Saint Joseph Regional Medical Center
-
-
Kansas
-
Kansas City、Kansas、アメリカ、66160-7357
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
-
-
Michigan
-
Ann Arbor、Michigan、アメリカ、48106
- CCOP - Michigan Cancer Research Consortium
-
Grand Rapids、Michigan、アメリカ、49503
- CCOP - Grand Rapids
-
Kalamazoo、Michigan、アメリカ、49007-3731
- CCOP - Kalamazoo
-
-
Minnesota
-
Saint Louis Park、Minnesota、アメリカ、55416
- CCOP - Metro-Minnesota
-
-
Mississippi
-
Jackson、Mississippi、アメリカ、39216-4505
- University of Mississippi Medical Center
-
-
Missouri
-
Columbia、Missouri、アメリカ、65203
- Ellis Fischel Cancer Center at University of Missouri - Columbia
-
Kansas City、Missouri、アメリカ、64131
- CCOP - Kansas City
-
Springfield、Missouri、アメリカ、65807
- CCOP - Cancer Research for the Ozarks
-
-
Nebraska
-
Omaha、Nebraska、アメリカ、68106
- CCOP - Missouri Valley Cancer Consortium
-
-
New York
-
Brooklyn、New York、アメリカ、11203
- SUNY Downstate Medical Center
-
Stony Brook、New York、アメリカ、11790-7775
- Long Island Cancer Center at Stony Brook University Hospital
-
-
North Carolina
-
Chapel Hill、North Carolina、アメリカ、27599-7295
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
-
-
Ohio
-
Cleveland、Ohio、アメリカ、44106
- Ireland Cancer Center
-
Cleveland、Ohio、アメリカ、44124
- Cleveland Clinic Taussig Cancer Center
-
Columbus、Ohio、アメリカ、43222
- Mount Carmel West Hospital
-
-
Oklahoma
-
Oklahoma City、Oklahoma、アメリカ、73190
- University of Oklahoma College of Medicine
-
-
Oregon
-
Portland、Oregon、アメリカ、97225
- CCOP - Columbia River Oncology Program
-
-
Pennsylvania
-
Abington、Pennsylvania、アメリカ、19001-3788
- Abington Memorial Hospital
-
Danville、Pennsylvania、アメリカ、17822-2001
- CCOP - Geisinger Clinic and Medical Center
-
Hershey、Pennsylvania、アメリカ、17033-0850
- Penn State Cancer Institute at Milton S. Hershey Medical Center
-
Philadelphia、Pennsylvania、アメリカ、19111
- Fox Chase Cancer Center
-
Pittsburgh、Pennsylvania、アメリカ、15213-3180
- Magee-Womens Hospital
-
-
Tennessee
-
Knoxville、Tennessee、アメリカ、37917
- Southeast Gynecologic Oncology Associates
-
Nashville、Tennessee、アメリカ、37232-2516
- Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center
-
-
Texas
-
Temple、Texas、アメリカ、76508
- CCOP - Scott and White Hospital
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
DISEASE CHARACTERISTICS:
Histologically confirmed endometrial carcinoma that is refractory to curative therapy or established treatment
- Clinically and/or histologically confirmed persistent or recurrent disease
Measurable disease by physical examination or medical imaging
- Sonography allowed if lesions are clearly defined on initial examination and bidimensionally measurable
- Ascites or pleural effusions not considered measurable
Must have received 1 prior cytotoxic therapy regimen
- May include high-dose therapy, consolidation, or extended therapy after surgical or nonsurgical assessment
1 additional noncytotoxic regimen allowed
Biologic or cytostatic agents include, but are not limited to:
- Monoclonal antibodies
- Cytokines
- Small-molecule inhibitors of signal transduction
- Ineligible for a higher priority GOG protocol
- No known brain metastases
PATIENT CHARACTERISTICS:
Age
- 18 and over
Performance status
- GOG 0-2 if received 1 prior therapy regimen
- GOG 0-1 if received 2 prior therapy regimens
Life expectancy
- Not specified
Hematopoietic
- Absolute neutrophil count at least 1,500/mm^3
- Platelet count at least 100,000/mm^3
Hepatic
- Bilirubin no greater than 1.5 times upper limit of normal (ULN)
- SGOT no greater than 2.5 times ULN
- Alkaline phosphatase no greater than 2.5 times ULN
Renal
- Creatinine no greater than 1.5 times ULN
Cardiovascular
- No symptomatic congestive heart failure, unstable angina pectoris, or cardiac arrhythmia
Neurologic
- No sensory or motor neuropathy greater than grade 1
- No residual neuropathy attributed to prior chemotherapy or other chronic conditions (e.g., diabetes, venous stasis, or carpal tunnel syndrome)
Other
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
- No history of allergy to platinum compounds or antiemetics
- No active infection requiring antibiotics
- No other uncontrolled illness
- No other invasive malignancies within the past 5 years except nonmelanomatous skin cancer
PRIOR CONCURRENT THERAPY:
Biologic therapy
- See Disease Characteristics
- At least 14 days since prior pegfilgrastim
- At least 24 hours since other prior growth factors
- At least 3 weeks since prior biologic or immunologic therapy
- No concurrent growth factors during first course of study therapy
Chemotherapy
- See Disease Characteristics
- At least 4 weeks since prior chemotherapy and recovered
- No more than 1 prior cytotoxic chemotherapy regimen, either single or combination cytotoxic drug therapy
- No prior oxaliplatin
Endocrine therapy
- At least 1 week since prior hormonal therapy directed at tumor
- Concurrent hormone replacement therapy allowed
Radiotherapy
- At least 4 weeks since prior radiotherapy and recovered
Surgery
- Recovered from any recent surgery
Other
- At least 3 weeks since prior therapy for endometrial cancer
- No other concurrent investigational agents
- No prior anticancer therapy that would preclude study participation
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- マスキング:なし(オープンラベル)
協力者と研究者
捜査官
- スタディチェア:Paula M. Fracasso, MD, PhD、Washington University Siteman Cancer Center
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
子宮内膜癌の臨床試験
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); Highlight Therapeutics積極的、募集していない平滑筋肉腫 | 悪性末梢神経鞘腫瘍 | 滑膜肉腫 | 未分化多形肉腫 | 骨の未分化高悪性度多形肉腫 | 粘液線維肉腫 | II期の体幹および四肢の軟部肉腫 AJCC v8 | III期の体幹および四肢の軟部肉腫 AJCC v8 | IIIA 期の体幹および四肢の軟部肉腫 AJCC v8 | IIIB 期の体幹および四肢の軟部肉腫 AJCC v8 | 切除可能な軟部肉腫 | 多形性横紋筋肉腫 | 切除可能な脱分化型脂肪肉腫 | 切除可能な未分化多形肉腫 | 軟部組織線維肉腫 | 紡錘細胞肉腫 | ステージ I 後腹膜肉腫 AJCC (American Joint Committee on Cancer) v8 | 体幹および四肢の I 期軟部肉腫 AJCC v8 | ステージ... およびその他の条件アメリカ
オキサリプラチンの臨床試験
-
Hospices Civils de Lyonわからない